CN Patent

CN103957887A — 包含前列腺素F2α衍生物和透明质酸的眼用组合物

Assigned to Unintel Pharmaceutical Co · Expires 2014-07-30 · 12y expired

What this patent protects

本发明涉及一种包含至少一种前列腺素类似物作为活性化合物和稳定量的至少一种透明质酸或其盐的组合物，所述组合物不含防腐剂；并且涉及其用于治疗有此需要的受试者中的高眼压症和/或青光眼的用途。

USPTO Abstract

本发明涉及一种包含至少一种前列腺素类似物作为活性化合物和稳定量的至少一种透明质酸或其盐的组合物，所述组合物不含防腐剂；并且涉及其用于治疗有此需要的受试者中的高眼压症和/或青光眼的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103957887A
Jurisdiction
CN
Classification
—
Expires
2014-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Unintel Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.